Completed PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT01701648

Melanocyte Transplantation for Patients With Stable Vitiligo.

Phase I-II, Randomized, Intraindividually Placebo Controlled Clinical Trial, to Evaluate the Efficacy of Autologous Melanocyte Transplantion on Amniotic Membrane as a Substrate for Patients With Stable Vitiligo.

Sponsor: Clinica Universidad de Navarra, Universidad de Navarra

Conditions Stable Vitiligo

Interventions Laser CO2

Updated 6 times since 2017 Last updated: Oct 11, 2013 Started: Dec 31, 2010 Primary completion: Jan 31, 2013 Completion: Jun 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1/PHASE2 trial investigates Stable Vitiligo and is currently completed. Clinica Universidad de Navarra, Universidad de Navarra leads this study, which shows 6 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Oct 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Jan 2021 — Oct 2021 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1_PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2

First recorded

Dec 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Clinica Universidad de Navarra, Universidad de Navarra
Spanish Clinical Research Network - SCReN

Data source: Clinica Universidad de Navarra, Universidad de Navarra

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Pamplona, Spain